Please assess the completion status of the following clinical trial:

Trial Title: A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients having chronic anemia and chronic renal failure~* have lessened physical function~* be community dwelling (defined as not admitted to an assisted nursing facility, nursing home or hospital at the time of enrollment. An assisted nursing facility is considered any living situation where daily care is being provided by recognized health care professionals from that facility.)~Exclusion Criteria:~* History of bacterial infection requiring hospitalization and intravenous antibiotics or transfusion within 1 month prior to enrollment~* anemia due to iron, folate, or vitamin B12 deficiency~* gastrointestinal bleeding~* anticipated to begin dialysis within 4 months following enrollment into the study~* History of thrombotic disease within the past 3 months, or on anticoagulation therapy at enrollment.

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).